ISIN | LU0030165871 |
---|---|
Valor Number | 595157 |
Bloomberg Global ID | |
Fund Name | SEB Fund 1 - SEB Nordic Future Opportunity Fund C |
Fund Provider |
SEB Funds AB
SEB Investment Management AB SE-106 40 Stockholm Sweden |
Fund Provider | SEB Funds AB |
Representative in Switzerland |
Société Générale Paris, Succursale de Zurich Zürich Phone: +41 58 272 31 11 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Fund’s investment objective is to increase the value of your investment over time while seeking to create a positive environmental and social impact to achieve, inter alia, the long-term objectives of the Paris Agreement, VINX Benchmark Cap Net Return Index, a measure of performance of Nordic companies that does not take into account ESG factors and is not aligned with the sustainable objective of the sub-fund. |
Peculiarities |
Current Price * | 17.49 EUR | 15.04.2025 |
---|---|---|
Previous Price * | 17.33 EUR | 14.04.2025 |
52 Week High * | 22.46 EUR | 12.07.2024 |
52 Week Low * | 16.10 EUR | 09.04.2025 |
NAV * | 17.49 EUR | 15.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 187,899,069 | |
Unit/Share Assets *** | 52,938,680 | |
Trading Information SIX |
YTD Performance | -10.83% |
30.12.2024 - 15.04.2025
30.12.2024 15.04.2025 |
---|---|---|
YTD Performance (in CHF) | -12.00% |
30.12.2024 - 15.04.2025
30.12.2024 15.04.2025 |
1 month | -10.96% |
17.03.2025 - 15.04.2025
17.03.2025 15.04.2025 |
3 months | -11.52% |
15.01.2025 - 15.04.2025
15.01.2025 15.04.2025 |
6 months | -18.35% |
15.10.2024 - 15.04.2025
15.10.2024 15.04.2025 |
1 year | -22.13% |
12.07.2024 - 15.04.2025
12.07.2024 15.04.2025 |
2 years | +5.03% |
29.09.2023 - 15.04.2025
29.09.2023 15.04.2025 |
3 years | -13.98% |
19.04.2022 - 15.04.2025
19.04.2022 15.04.2025 |
5 years | +0.74% |
05.03.2021 - 15.04.2025
05.03.2021 15.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk AS Class B | 9.29% | |
---|---|---|
Atlas Copco AB Class A | 6.49% | |
AstraZeneca PLC | 6.27% | |
Hexagon AB Class B | 5.39% | |
EQT AB Ordinary Shares | 3.53% | |
ABB Ltd | 3.33% | |
Schneider Electric SE | 2.72% | |
Zealand Pharma AS | 2.71% | |
Addtech AB Class B | 2.70% | |
Yubico AB | 2.61% | |
Last data update | 28.02.2025 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.20% |
Ongoing Charges *** | 1.25% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |